Infecções oportunistas em onco-hematologia: desafios no manejo de pacientes pediátricos imunossuprimidos com leucemias agudas
DOI:
https://doi.org/10.34119/bjhrv8n6-259Keywords:
leucemias agudas, infecções oportunistas, imunossupressãoAbstract
Este estudo aborda como ocorre o manejo clínico de crianças e adolescentes diagnosticados com leucemias agudas e que, devido ao quadro de imunossupressão provocado pela doença e pelas terapias antineoplásicas, são acometidos por infecções provocadas por patógenos como bactérias, fungos e vírus. Nesse cenário, é importante compreender os riscos inerentes a essas infecções, os microrganismos de maior prevalência e as estratégias de controle para redução das complicações clínicas e melhor condução dos casos. O objetivo é analisar como as infecções oportunistas em pacientes pediátricos com leucemias agudas são diagnosticadas, seus fatores de risco, as terapias adotadas, a profilaxia e o manejo clínico. A metodologia consiste em uma revisão narrativa de literatura em que foram utilizados artigos publicados nos últimos dez anos e disponibilizados em plataformas de pesquisas acadêmicas como SciELO, PubMed, Education Sciences e Portal CAPES. Constatou-se a gravidade das infecções nos pacientes, além de identificar os protocolos de tratamento mais eficazes para combatê-las. Com isso, o manejo terapêutico e multidisciplinar contribui para a redução nas taxas de morbimortalidade de crianças e adolescentes, além da promoção à saúde e qualidade de vida.
References
ALISHLASH, A et al. Mycoplasma pneumoniae Carriage With De Novo Macrolide-Resistance and Breakthrough Pneumonia. Pediatrics, 2019. Disponivel em: https://doi.org/10.1542/peds.2019-1642
ALQASIM A , JAFFAL A , ALYOUSEF A. Prevalence of Multidrug Resistance and Extended-Spectrumβ-Lactamase Carriage of Clinical Uropathogenic Escherichia coliIsolates in Riyadh, Saudi Arabia. International Journal of Microbiology. 2018. Disponível em: https://doi.org/10.1155/2018/3026851
BAJANTRIA, B; VENKATRAMA S; DIAZ-FUENTESA G. Mycoplasma pneumoniae: A Potentially Severe Infection. J Clin Med Res, p. 535-544, 2018. Disponível em: https://doi.org/10.14740/jocmr3421w
BOZTUG et al. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia. Ann Hematol, 2016. Disponível em: DOI 10.1007/s00277-016-2833-5
CARRASCO SALAS, P.; LAPUNZINA, P.; PÉREZ-MARTÍNEZ, A. Predisposición genética al cáncer infantil. Anales de Pediatría, v. 87, n. 3, p. 125–127, set. 2017. Disponível em: https://pubmed.ncbi.nlm.nih.gov/28283310
COSS, M. E. P. Infecções oportunistas causadas por bactérias nas leucemias linfóide e mielóide. Mar. 2025. Disponível em: https://ciencianews.com.br/arquivos/ACET/IMAGENS/biblioteca-digital/hematologia/serie_branca/leucemias_linfomas_mieloma/leucemias/94_Maria%20Eduarda%20Coss.pdf. Acesso em: 18 ago. 2025.
DUBOIS M. M. et al. Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Recipients. Global Pediatric Health Volume 8: 1 –15. 2020. Disponível em: https://doi.org/10.1177/2333794X20981548
ELGARTEN, C. W. et al. Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children’s Oncology Group. Pediatric Blood & Cancer, v. 69, n. 11, 9 set. 2022. disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC9529813
GABUTTI, G. et al. Viral Respiratory Infections in Hematological Patients. Infectious Diseases and Therapy, v. 9, n. 3, p. 495–510, 7 jul. 2020. Disponível em: https://link.springer.com/article/10.1007/s40121-020-00313-6
HILL, J. A. Human herpesvirus 6 in transplant recipients. Current Opinion in Infectious Diseases, v. 32, n. 6, p. 584–590, dez. 2019. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC7141773
HISKEY, L. et al. Prevention and management of human cytomegalovirus in pediatric HSCT recipients: A review. Frontiers in Pediatrics, v. 10, 23 nov. 2022. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC9727199
KATARZYNA ADAMCZEWSKA-WAWRZYNOWICZ et al. Modern treatment strategies in pediatric oncology and hematology. Discover Oncology, v. 14, n. 1, 14 jun. 2023. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC10267092
LARISSA, S. Frequência de Leucemia na infância e adolescência em serviço de Oncologia Pediátrica da Paraíba. Ufcg.edu.br, 2017. Disponível em: https://dspace.sti.ufcg.edu.br/jspui/handle/riufcg/30727
LEHRNBECHER, T. et al. Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update. Journal of Clinical Oncology, v. 41, n. 9, p. 1774–1785, 20 mar. 2023. DOI: https://pubmed.ncbi.nlm.nih.gov/36689694/
LIU et al. Characteristics in gut microbiome is associated with chemotherapy-induced pneumonia in pediatric acute lymphoblastic leukemia. BMC Cancer, 2021, Disponível em: https://doi.org/10.1186/s12885-021-08917-y
MARÍA ELENA SANTOLAYA et al. Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial. Journal of Antimicrobial Chemotherapy, v. 73, n. 10, p. 2860–2866, 13 jul. 2018. Disponível em: https://pubmed.ncbi.nlm.nih.gov/30010931/
MCCORMICK et al. Cost-Effectiveness of Levofloxacin Prophylaxis Against Bacterial Infection in Pediatric Patients With Acute Myeloid Leukemia. Pediatr Blood Cancer. Outubro de 2020. Disponível em: doi:10.1002/pbc.28469.
MCCORMICK, M. et al. Cost‐effectiveness of levofloxacin prophylaxis against bacterial infection in pediatric patients with acute myeloid leukemia. Pediatric Blood & Cancer, v. 67, n. 10, 25 jul. 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32710709/
MORAES-PINTO, M. I. DE .; FERRARINI, M. A. G.. Opportunistic infections in pediatrics: when to suspect and how to approach. Jornal de Pediatria, v. 96, p. 47–57, mar. 2020.
NAHID P. et al. Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. Am J Respir Crit Care Med. 2019 Nov 15;200(10):e93-e142. doi: 10.1164/rccm.201909-1874ST.
OLIVEIRA, A. P. DA C. et al. Cuidado de enfermagem às crianças com leucemia em um hospital de alta complexidade. Research, Society and Development, v. 10, n. 3, p. e14410313142–e14410313142, 10 mar. 2021. DOI: 10.33448/rsd-v10i3.13142.
PEQUENO, M. A. P.; LUCENA, J. N. Leucemia linfoide aguda em crianças – diagnóstico precoce e abordagens terapêuticas atuais: uma revisão integrativa de literatura. Lumen et Virtus, [S. l.], v. 16, n. 50, p. 9087–9105, 2025. DOI: 10.56238/levv16n50-072
PONCE-DE-LEON et al. Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). PLoS One, 2018. Disponível em: doi: 10.1371/journal.pone.0198621
RAHAL, Z. et al. Genomics of adult and pediatric solid tumors. American Journal of Cancer Research, v. 8, n. 8, p. 1356, ago. 2018. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC6129500
SATOSHI KUTSUNA et al. Association Between Early Initiation of Anti-Herpesvirus Therapy and Outcomes in herpesvirus Encephalitis: A Nationwide Retrospective Propensity Score Analysis in Japan. International Journal of Infectious Diseases, p. 107997–107997, 1 jul. 2025. Disponível em: https://doi.org/10.1016/j.ijid.2025.107997
Loutfy, S.A., Abo-Shadi, M.A., Fawzy, M. et al. Epstein-Barr virus and cytomegalovirus infections and their clinical relevance in Egyptian leukemic pediatric patients. Virol J 14, 46 (2017). https://doi.org/10.1186/s12985-017-0715-7
ELITZUR, S. et al. EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy. Blood, v. 141, n. 7, p. 743–755, 4 nov. 2022. Disponível em: https://doi.org/10.1182/blood.2022016975
SCHLAGE, S. et al. SARS-CoV-2 in pediatric cancer: a systematic review. European Journal of Pediatrics, v. 181, n. 4, p. 1413–1427, 10 jan. 2022. DOI: https://doi.org/10.1007/s00431-021-04338-y
HASHMI, S. K. et al. COVID-19 in Pediatric Patients With Acute Lymphoblastic Leukemia or Lymphoma. JAMA network open, v. 7, n. 2, p. e2355727–e2355727, 16 fev. 2024. Disponível em: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2815232
MUKKADA, S. et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. The Lancet Oncology, v. 22, n. 10, p. 1416–1426, out. 2021. Disponível em: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00454-X/fulltext
ELEFTHERIA KAMPOURI; HANDLEY, G.; HILL, J. A. Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape. Viruses, v. 16, n. 4, p. 498–498, 24 mar. 2024. Disponíveis em: https://doi.org/10.3390/v16040498
STATHIS, C. J. et al. A systematic review and meta-analysis of HHV-6 and mortality after hematopoietic cell transplant. Bone Marrow Transplantation, 8 set. 2024. Disponível em: https://doi.org/10.1038/s41409-024-02398-w
GALLANT, R. et al. Clinical characteristics of cytomegalovirus‐positive pediatric acute lymphoblastic leukemia at diagnosis. American Journal of Hematology, v. 97, n. 6, 17 mar. 2022. Disponível em: https://doi.org/10.1002/ajh.26528
STATHIS, C. J. et al. A systematic review and meta-analysis of HHV-6 and mortality after hematopoietic cell transplant. Bone Marrow Transplantation, 8 set. 2024. Disponível em: https://doi.org/10.1038/s41409-024-02398-w
NONTHAPAN PHASUK et al. Monitoring of cytomegalovirus infection in non-transplant pediatric acute lymphoblastic leukemia patients during chemotherapy. Medicine, v. 98, n. 4, p. e14256–e14256, 1 jan. 2019. Disponível em: https://doi.org/10.1097/md.0000000000014256
HILL, J. A. Human herpesvirus 6 in transplant recipients. Current Opinion in Infectious Diseases, v. 32, n. 6, p. 584–590, dez. 2019. Disponível em: https://doi.org/10.1097/QCO.0000000000000592
DEVASSY T.V. et al. Tuberculosis and childhood cancer – A review of literature. Indian Journal of Tuberculosis. Volume 70, Supplement 1, 2023, Pages S39-S48. Disponível em: https://doi.org/10.1016/j.ijtb.2023.09.006
SEKOWSKA et al. Infections with Klebsiella pneumoniae in Children Undergoing Anticancer Therapy or Hematopoietic Cell Transplantation: A Multicenter Nationwide Study. J. Clin. Med, 2024. Disponivel em: https://doi.org/ 10.3390/jcm13144078
SUÁREZ I. et al. The Diagnosis and Treatment of Tuberculosis. Deutsches Ärzteblatt International. Dtsch Arztebl Int 2019; 116: 729–35. Disponivel em: https://doi.org/10.3238/arztebl.2019.0729
SYED IBRAHIM BUKHARI; JEHAN, F.; ASIM BELGAUMI. Global Immunization Crisis Amid the COVID-19 Pandemic: Implications for Pediatric Oncology. JCO global oncology, n. 10, 1 fev. 2024. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC10914242
RYBKA, K.; TURKIEWICZ, D. Virus infection in children after allogenic stem cell transplantation . Postepy higieny i medycyny doswiadczalnej, v. 57, n. 1, p. 3–17, 2003. Disponível em: https://pubmed.ncbi.nlm.nih.gov/12765120
VILLENEUVE, S; AFTANDILIAN C. Neutropenia and Infection Prophylaxis in Childhood Cancer. Current Oncology Reports, p. 671–686, 2022. Disponível em: https://doi.org/10.1007/s11912-022-01192-5
W, O.; GREEN, A. M. Fungal infections in children with haematologic malignancies and stem cell transplant recipients. British Journal of Haematology, v. 189, n. 4, p. 607–624, 11 mar. 2020. DOI: https://pubmed.ncbi.nlm.nih.gov/32159231/
GIANLUCA BOSSÙ et al. Novel Insights into Fungal Infections Prophylaxis and Treatment in Pediatric Patients with Cancer. Antibiotics, v. 11, n. 10, p. 1316–1316, 27 set. 2022. DOI: https://www.mdpi.com/2079-6382/11/10/1316
NIKOLETA KAZAKOU et al. Invasive fungal infections in a pediatric hematology-oncology department: A 16-year retrospective study. Current medical mycology, 23 maio 2020. DOI: https://pubmed.ncbi.nlm.nih.gov/33628980/
CALLE-MIGUEL, L. et al. Changes in the epidemiology of invasive fungal disease in a Pediatric Hematology and Oncology Unit: the relevance of breakthrough infections. BMC infectious diseases, v. 23, n. 1, 25 maio 2023. DOI: https://pubmed.ncbi.nlm.nih.gov/37226103/
PANA, Z. D. et al. Epidemiology of Invasive Fungal Disease in Children. Journal of the Pediatric Infectious Diseases Society, v. 6, n. suppl_1, p. S3–S11, 1 set. 2017. DOI: https://pubmed.ncbi.nlm.nih.gov/28927200/
BENISH, M. et al. Invasive Fusariosis in Pediatric Hematology/Oncology and Stem Cell Transplant Patients: A Report from the Israeli Society of Pediatric Hematology-Oncology. Journal of fungi (Basel, Switzerland), v. 8, n. 4, p. 387, nov. 2022. DOI: https://pubmed.ncbi.nlm.nih.gov/35448618/
WATTIER, R.; RAMIREZ-AVILA, L. Pediatric Invasive Aspergillosis. Journal of Fungi, v. 2, n. 2, p. 19, 13 jun. 2016. DOI: https://pmc.ncbi.nlm.nih.gov/articles/PMC5753081/
PAPACHRISTOU, S.; IOSIFIDIS, E.; ROILIDES, E. Invasive Aspergillosis in Pediatric Leukemia Patients: Prevention and Treatment. Journal of Fungi, v. 5, n. 1, p. 14, 11 fev. 2019. DOI: https://www.mdpi.com/2309-608X/5/1/14
GAL ETZIONI, T. R. et al. Invasive Fungal Infections in Children with Acute Leukemia: Epidemiology, Risk Factors, and Outcome. Microorganisms, v. 12, n. 1, p. 145, 11 jan. 2024. DOI: https://www.mdpi.com/2076-2607/12/1/145
WEELDEREN et al. Effect of Antibacterial Prophylaxis on Febrile Neutropenic Episodes and Bacterial Bloodstream Infections in Dutch Pediatric Patients with Acute Myeloid Leukemia: A Two-Center Retrospective Study. Cancers, 2022. Disponível em: https://doi.org/10.3390/ cancers14133172
WEN et al. Impact of doxycycline on mycoplasma pneumonia treatment and cancer prognosis in pediatric leukemia patients post-chemotherapy: a target trial emulation. Am J Cancer Res, p. 1790-1805, 2025. Disponível em: https://doi.org/10.62347/KGBQ9641
ZAHNREICH, S.; SCHMIDBERGER, H. Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies. Cancers, v. 13, n. 11, p. 2607, 26 maio 2021. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC8198981
ZEIN et al. The challenge of multidrug resistance in hospitalized pediatric patients with urinary tract infections. Front. Cell. Infect. Microbiol. 2025. Disponível em: 10.3389/fcimb.2025.1570405
